Two different types of focal preneoplastic lesions, tentatively named Type I and II lesions, were recognized in the liver of rats chronically treated with clofibrate for 104 weeks. Type I lesions were characterized by mostly negative glucose-6-phosphate dehydrogenase (G6PD) activity (6 out of 10, 60%) and positive expression of succinate dehydrogenase (10 out of 10, 100%), in addition to the previously documented complete lack of expression of glutathione Stransferase, placenta! form (GST-P) and y-glutamyl transpeptidase (GGT). Furthermore, most importantly, Type I lesions exhibited a clear decrease in immunohistocnemically demonstrated connexin32 (Cx32) spot counts on their hepatocyte membranes, similarly to nitrosamine-induced lesions. In contrast, Type II lesions, mostly small in size and positively expressing GST-P and/or GGT and G6PD, similarly to their previously reported nitrosamine-induced counterparts, did not exhibit a significant decrease in Cx32 count. In addition, spontaneously occurring lesions, again sharing the same enzyme phenotype, did not show a decrease in Cx32. The results indicate that: (i) a clear distinction between the two lesions, with Type I being involved in clofibrate-induced tumors and Type II being more likely to be spontaneous in nature; (ii) a decrease in Cx32 is closely linked to lesion development and possibly stage of progression, irrespective of the enzyme phenotype and the applied carcinogen; (iii) the unaltered condition of Cx32 may suggest a slow growing or non-progressive nature.
Introduction
Chemically induced preneoplastic hepatocyte lesions exhibit various enzyme alterations, such as increased y-glutamyl transpeptidase (GGT*), glucose-6-phosphate dehydrogenase
•Abbreviations: GGT, Y-glutamyl transpeptidase; G6PD, glucose-6-phosphate dehydrogenase; GST-P, glutathione S-transferase, placental form; G6P, glucose-6-phosphatase; ATPase, adenosine triphosphatase; GJIC, gap junctional intercellular communication; Cx32, connexin 32; EHEN, yV-ethyl-A'-hydroxyethylnitrosamine; SD, succinate dehydrogenase.
(G6PD) and the glutathione S-transferase, placental form (GST-P) (1-5), as well as decreased glucose-6-phosphatase (G6P) and adenosine triphosphatase (ATPase), all of which have been used as markers for lesion development. We have reported that the degree of phenotypic change in terms of numbers of enzyme alterations within the same lesion shows a good correlation with the stage of nitrosamine-induced neoplastic development from early enzyme-altered foci to adenomas and carcinomas (6) .
Gap junctional intercellular communication (GJIC) involving connexin proteins is known to play an important role in maintaining tissue homeostasis by transducing messengers responsible for control of metabolism and cell proliferation (7) . Aberrant GJIC expression has been shown to be strongly associated with neoplastic transformation and its interruption appears to be directly relevant to failure of homeostatic control and resultant tumor development (8, 9) . In the rat liver, nitrosamine-induced preneoplastic and neoplastic lesions, such as early focal lesions, adenomas and hepatocellular carcinomas, show obvious decreases in levels of liver-specific connexin32 (Cx32) mRNA and its immunohistochemically demonstrated protein (10) (11) (12) (13) .
With regard to lesions induced by peroxisome proliferators, a clear difference in altered enzyme expression as compared with those induced by unequivocally genotoxic carcinogens has been reported, but their Cx32 expression status has not yet been clarified (1,4,6). The present investigation was therefore conducted to characterize enzyme phenotype expression and assess Cx32 protein expression in preneoplastic lesions induced by clofibrate, a member of the peroxisome proliferator group of carcinogens, as well as in spontaneously occurring lesions (14) (15) (16) (17) (18) (19) . The results were compared with our previous findings for lesions induced by A///-diethylnitrosamine and A'-ethyl-N-hydroxyethylnitrosamine (EHEN) (5, 6, 10) , with a focus on any correlation with progression during hepatocarcinogenesis.
Materials and methods

Animals and experimental schedule
Male 6-week-old Wistar rats (Charles River Japan Inc., Atsugi, Japan) were used. They were maintained on basal diet (Oriental MF, Oriental Yeast Co. Ltd, Tokyo, Japan) ad libitum and housed in plastic cages in an air-conditioned room at 24 ± 2°C and 60 ± 5% humidity For the induction of preneoplastic and neoplastic hepatocyte lesions, rats were placed on basal diet containing 0.5% clofibrate (Tokyo Chemical Industry Co. Ltd, Tokyo, Japan) until killed after 104 weeks (seven rats). Untreated control animals were also killed at the same age as the clofibrate-treated group (five rats).
Histochemistry and immunohislochemistry
Immediately upon sacrifice, the livers were excised and slices 4-5 mm thick were cut with a razor blade and immersed in isopentane pre-cooled to -130°C in a liquid nitrogen bath. They were stored at -80°C in a deep freeze until use. Serial sections cut at 4 ujn were used for the histochemical demonstration of G6PD and succinate dehydrogenase (SD), by semi-permeable membrane methods (20), and of G6P, ATPase and GGT activities (21) . For immunohistochemical staining of GST-P and Cx32, frozen sections were fixed in acetone, pre-cooled to -20"C, before treatment with a polyclonal antibody against GST-P (22,23) at a dilution of 1:5000 or monoclonal antibody against
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Cx32 (24, 25) at a dilution of 1:200. Binding sites were demonstrated by the avidin-biotin-peroxidase complex (ABC) method (Vectastajn Kit, Vector Laboratories Inc., Burlingame, CA), using diaminobenzidine-H202, and sections were then lightly counterstained with hematoxylin. For hematoxyhn and eosin staining, frozen sections were fixed in buffered formalin.
Analysis of enzyme expression
For the analysis of altered enzyme and Cx32 expression, lesions conventionally classified as enzyme-altered foci and adenomas were grouped together and termed lesions (26, 27) . Individual lesions demonstrating the respective enzyme alteration, regarded as present when more than half of the focal lesion area was involved, were traced and overlaid on a sheet of paper using a Microfiche Plaque Viewer (Carl Zeiss, Jena, Germany) at a magnification of I3X. Detection and counting of hepatocellular lesions was by reference to enzymealtered focal lesions expressing any of the six different enzymes. When the lesion expressed increased activity or protein localization as compared with surrounding hepatocytes, it was termed 'positively expressed' and, similarly, when decreased, 'negatively expressed'. The detected lesions were overlaid on sheets traced from the corresponding hematoxylin and eosin stained section for any correlation with basophilic appearance. The diameter of each lesion projected on paper was calculated from the mean value of diameter measured at three sites with 60° rotations and used for analysis of size distribution. Lesions with a largest diameter exceeding twice the smallest were excluded. Ten Type I and 89 Type II lesions in clofibrate-treated livers and 30 spontaneously occurring lesions in untreated liver were included in the analysis.
Quantitative analysis of Cx32 localization
Counting of Cx32 spots was performed using a microscope equipped with a grid-mesh eye piece lens, which allowed ~25O-300 normal hepatocytes to be counted within one field at 400X magnification. Cx32 values were calculated by counting the number of immunohistochemically demonstrated Cx32 spots (connexons) on hepatocyte membranes, expressed as the number of spots/ hepatocyte. Statistical analyses were performed using Dunnet's test.
Results
Enzyme expression characteristics
Two different types of lesions were recognized in the livers of clofibrate-treated rats. The first, tentatively named Type I, was characterized by a lack of either GST-P or GGT in all of 10 lesions examined (100%) and negative expression (decreased as compared with the surrounding cells) of ATPase in seven (70%) and/or G6P in six (60%). G6PD was negatively expressed in six (60%) and SD was positively expressed in all 10 (100%) (Figure 1 ). Type II lesions, characterized by positive expression of GST-P and/or GGT in 78 (87.6%) and 54 (60.7%) out of 89 lesions respectively, were also found within the same liver sections. Most of the Type II lesions were small and their enzyme phenotype was essentially the same as that previously observed for EHEN-induced lesions ( Figure 2 ). In the untreated livers, appreciable numbers of spontaneously occurring lesions were observed. Twenty eight (93.3%) lesions and 21 (70%) out of 30 were positive for GST-P and/or GGT respectively and their expression of other enzymes was essentially the same as that observed for Type II and EHEN-induced lesions ( Figure 3 and Table I ). In hematoxylin and eosin stained sections, the cytoplasm of two larger size Type I lesions, nearly 20 Type II lesions and five spontaneously occurring lesions appeared only slightly basophilic as compared with the surrounding hepatocytes. However, it was difficult to make a clear distinction between basophilic lesions and background tissue in frozen sections due to the existence of many intermediate lesions, which precluded reliable examination of any correlation between basophilia and enzyme phenotype or expression of Cx32. Therefore, recognition of early lesions was made solely on the basis of their altered enzyme phenotype.
Numbers of Type I and II lesions counted in the liver sections of clofibrate-treated animals and spontaneously occurring lesions were 3.42 ± 1.63, 14.33 ± 9.80 and 11.96 ± 2.95 lesions/cm 2 respectively. The values for both Type II and spontaneously occurring lesions were significantly greater (P < 0.001) than that for the Type I lesions, but not significantly different from each other (Figure 4 ). Mean diameters of Type I, Type II and spontaneously occurring lesions were 2.08 ± 1.63 (n = 10), 0.44 ± 0.25 (n = 89) and 0.26 ±0.015 mm {n = 30) respectively. There was considerable overlap in size, with six Type I and 14 Type II lesions falling within the 0.69-1.73 mm diameter size range ( Figure 5 ).
Quantitative analysis of Cx32 spots
In the livers of clofibrate-treated rats, the Cx32 counts/ hepatocyte were 0.15 ± 0.12 in Type I lesions (nine gridmesh areas from five lesions ranging from 0.69 to 2.31 mm in diameter), 2.30 ± 0.59 in Type II lesions (13 grid-mesh areas from 10 lesions ranging from 0.11 to 1.73 mm in diameter) and 1.95 ± 0.41 in surrounding hepatocytes (17 grid-mesh areas from five liver sections). In the livers of untreated rats, Cx32 count was 3.52 ± 0.82 (20 grid mesh area from 10 spontaneously occurring lesions ranging from 0.11 to 0.26 mm in diameter) in lesions and 3.71 ± 0.53 (nine grid-mesh areas from five liver sections) in surrounding hepatocytes. The value for Type I lesions was significantly decreased as compared with those for both Type II lesions and surrounding hepatocytes (P < 0.001). Values for Type II and spontaneously occurring lesions did not show a significant change as compared with the respective surrounding hepatocytes ( Figure 6 ). The relative decrease in Cx32 count of Type II lesions from spontaneously occurring lesions, at 65.3%, was similar to that of surrounding hepatocytes in clofibrate-treated liver from the untreated case, at 52.5%.
Discussion
The rationale for the present study of altered enzyme expression analysis is based on our previous finding that individual preneoplastic lesions induced by EHEN demonstrate a gradual shift towards larger numbers of" enzyme alterations with progression of neoplastic development, as monitored by the cell proliferation index (6) . In contrast to EHEN-induced lesions, peroxisome proliferator-induced Type I lesions characteristically lack expression of two of the most commonly positively expressed enzymes, GGT and GST-P (15, (28) (29) (30) (31) (32) (33) (34) (35) (36) , and negative expression of ATPase and G6P (36) (37) (38) (39) , as confirmed in the present study. We also found negative expression of G6PD, as observed by Greaves et al. (31) , and positivity for SD activity, similarly to the lesions induced by dehydroepiandrosterone (40). This offers a further contrast to Type II lesions and most nitrosamineinduced lesions (1,5,6). Since treatment with peroxisome proliferators, including clofibrate, does not generally alter the level of SD activity in the liver (41), the observed increase appears specific for lesions. Further investigations are necessary to clarify the physiological meaning of the shifts in these two key enzymes of carbohydrate metabolism, in terms of advantage for Type I lesion development.
Our earlier findings indicated a Cx32 reciprocity with increase in cells in S phase in the regenerating liver, suggesting that proliferating cells lose their capacity to express Cx32, possibly providing suitable conditions for cell division by blocking normal homeostatic control (13) . It was also earlier reported that Cx32 is decreased in terms of quantity and function in nitrosamine-induced GST-P-positive preneoplastic lesions in the rat (10, 24, 42, 43) . Furthermore, in EHEN-induced lesions, a decrease in Cx32 count was shown to significantly correlate with an increase in degree of alteration of enzyme expression, exhibiting an inverse relation to the stage of progression (13) . This is in contrast to the finding in transgenic rats bearing the SV40 antigen gene, demonstrating a decrease in Cx32 expression but a lack of positivity for GGT and GST-P (44). The latter findings, however, are closely in line with the results of the present investigation, indicating decreased Cx32 expression in lesions induced by clofibrate, a compound which profoundly influences enzyme phenotype (16) . Thus, the present study has revealed that a decreased Cx32 spot count in preneoplastic lesions is not dependent on the inducing or causative agent and is possibly intimately involved with neoplastic development.
Although the possibility of Type I lesions arising from Type II lesions by a conversion of their enzyme and Cx32 expression from those of Type II lesions under the influence of clofibrate cannot be excluded (15, 30, 45, 46) , the existence of a considerable number of both types of lesions in the same size range, 0.69-1.73 mm diameter ( Figure 5 ), indicates that the observed differences were not strictly dependent on lesion size, but rather may be attributed to a more fundamental difference. Moreover, since formation of 8-hydroxydeoxyguanosine was detected due to induction of hydrogen peroxide-generating peroxisomal enzymes such as fatty acyl-coenzyme A oxidase after treatment with peroxisome proliferators, it is possible that clofibrate may have caused genetic alterations relevant to initiation of hepatocarcinogenesis (47) (48) (49) (50) (51) .
It should be noted that while considerable numbers of Type II lesions were counted in clofibrate-treated livers, similar numbers was also observed in untreated liver ( Figure 5) . Furthermore, the shared characteristics of no significant decrease in Cx32 count and a common enzyme phenotype suggests that the Type II lesions might also be spontaneous in origin. Although earlier reports indicated that the carcinogenic mechanism of peroxi-2444 some proliferators might be due to promotion of spontaneously occurring hepatocytes showing cytoplasmic basophilia (39, 46, 52, 53) , it was impossible to provide any support for such a conclusion in the present study due to the difficulty in distinguishing basophilic lesions from other types in the current frozen sections.
Most importantly, Type II lesions found in the same clofibratetreated livers did not show any significant decrease in Cx32 count as compared with the surrounding hepatocytes, in line with the observations made for spontaneously occurring lesions in untreated liver (Figure 6 ), and the profile of altered enzyme expression was also essentially the same for both groups of Connexin32 in clofibratc hepatocarcinogenesis lesions (not shown). The similar reduction in Cx32 count in Type II lesions and background clofibrate-treated liver is also in agreement with a spontaneous origin, with reduction in both being due to the clofibrate treatment ( Figure 6 ).
Earlier reports that a lack of GJIC between neoplastic cells and surrounding normal cells is essential for maintenance of the transformed phenotypes (8, (11) (12) (13) 54) indicate that unchanged Cx32 expression within lesions may be associated with a non-progressive or reversible nature (55) . The members of the connexin gene family are considered to belong to the tumor suppressor gene group, because of their ability to control tumorigenicity of cells, with mutation-related aberrant expression being found in tumor cells and tissues (8, 11, (56) (57) (58) . Other connexin family members, such as connexin26 and connexin43, show variable alteration during the different stages of liver tumor development in the rat and in man, but no common regulatory mechanism of connexin expression has been elucidated and multiple mechanisms are rather thought to be responsible (58) . While recent studies indicated that GST-P gene expression is not directly regulated by transcriptional factors linked with possible oncogenes (59) , this assumption does not require a direct link. Accordingly, a decrease in Cx32 may be more relevant to carcinogenesis than GST-P expression. From our previous work and the current study, three types of preneoplastic lesions can be distinguished ( Figure 7 ): (i) nitrosamine-induced lesions, as earlier reported, exhibiting various enzyme alterations along with a decreased Cx32 count; (ii) clofibrate-induced lesions lacking expression of GST-P and/or GGT with decreased Cx32; (iii) spontaneously occurring lesions exhibiting similar enzyme alterations to their nitrosamine-induced counterparts but no alteration in Cx32 count. It should be noted that lesions exhibiting decreases in Cx32 may have a greater potential to progress to hepatocellular adenomas and carcinomas.
The present observations indicate an important role for GJIC in progression in hepatocarcinogenesis, Cx32 expression apparently correlating with cellular independence and growth advantage. In conclusion, a decrease in Cx32 count may be directly relevant to neoplastic development, irrespective of the enzyme phenotype and the inducing carcinogen.
